1. Home
  2. AGIO

as 05-24-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Founded: N/A Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 1.8B IPO Year: 2013
Target Price: $36.75 AVG Volume (30 days): 689.6K
Analyst Decision: Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -6.32 EPS Growth: N/A
52 Week Low/High: $19.80 - $35.50 Next Earning Date: 05-02-2024
Revenue: $29,403,000 Revenue Growth: 54.61%
Revenue Growth (this year): 155.52% Revenue Growth (next year): 82.76%

AGIO Daily Stock ML Predictions

Stock Insider Trading Activity of Agios Pharmaceuticals Inc. (AGIO)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
FOUSE JACQUALYN A AGIO Director Apr 8 '24 Sell $27.55 7,791 $214,642.05 137,396 SEC Form 4
Foster-Cheek Kaye I AGIO Director Mar 7 '24 Sell $31.62 1,285 $40,631.70 5,524 SEC Form 4
Foster-Cheek Kaye I AGIO Director Mar 5 '24 Sell $31.99 4,415 $141,235.85 6,809 SEC Form 4
Foster-Cheek Kaye I AGIO Director Mar 5 '24 Sell $32.21 300 $9,663.00 11,224 SEC Form 4
Washburn Theodore James Jr. AGIO Principal Accounting Officer Mar 5 '24 Sell $31.75 1,913 $60,737.75 2,886 SEC Form 4
Burns James William AGIO Chief Legal Officer Mar 1 '24 Sell $32.57 1,349 $43,936.93 37,169 SEC Form 4
Gheuens Sarah AGIO Chief Medical Officer Mar 1 '24 Sell $32.57 1,293 $42,113.01 36,415 SEC Form 4
Gheuens Sarah AGIO Chief Medical Officer Mar 1 '24 Sell $32.57 1,349 $43,936.93 39,066 SEC Form 4
Washburn Theodore James Jr. AGIO Principal Accounting Officer Mar 1 '24 Sell $32.57 295 $9,608.15 3,368 SEC Form 4
Washburn Theodore James Jr. AGIO Principal Accounting Officer Mar 1 '24 Sell $32.57 919 $29,931.83 4,799 SEC Form 4
Goff Brian AGIO Chief Executive Officer Mar 1 '24 Sell $32.57 4,156 $135,360.92 53,780 SEC Form 4
Burns James William AGIO Chief Legal Officer Mar 1 '24 Sell $32.57 1,293 $42,113.01 34,518 SEC Form 4
Jones Cecilia AGIO Chief Financial Officer Mar 1 '24 Sell $32.57 672 $21,887.04 14,840 SEC Form 4
Schenkein David P AGIO Director Feb 27 '24 Sell $33.60 11,858 $398,428.80 122,854 SEC Form 4
Schenkein David P AGIO Director Feb 27 '24 Sell $34.89 57,471 $2,005,163.19 122,854 SEC Form 4
Schenkein David P AGIO Director Feb 23 '24 Sell $33.19 20,411 $677,441.09 122,854 SEC Form 4
Schenkein David P AGIO Director Feb 23 '24 Sell $33.05 47,731 $1,577,509.55 122,854 SEC Form 4
Washburn Theodore James Jr. AGIO Principal Accounting Officer Feb 20 '24 Sell $26.63 504 $13,421.52 2,741 SEC Form 4
Washburn Theodore James Jr. AGIO Principal Accounting Officer Feb 12 '24 Sell $25.14 273 $6,863.22 3,245 SEC Form 4
Gheuens Sarah AGIO Chief Medical Officer Feb 12 '24 Sell $25.14 642 $16,139.88 33,431 SEC Form 4
Burns James William AGIO Chief Legal Officer Jan 20 '24 Sell $21.64 1,708 $36,961.12 30,378 SEC Form 4
FOUSE JACQUALYN A AGIO Director Jan 20 '24 Sell $21.64 10,722 $232,024.08 129,253 SEC Form 4
Gheuens Sarah AGIO Chief Medical Officer Jan 20 '24 Sell $21.64 1,708 $36,961.12 31,911 SEC Form 4
Jones Cecilia AGIO Chief Financial Officer Jan 20 '24 Sell $21.64 1,886 $40,813.04 13,069 SEC Form 4
Goff Brian AGIO Chief Executive Officer Jan 20 '24 Sell $21.64 7,635 $165,221.40 49,436 SEC Form 4

Share on Social Networks: